Peer review reports
From: Ttc39c is a potential target for the treatment of lung cancer
Original Submission | ||
---|---|---|
8 Jul 2022 | Submitted | Original manuscript |
Resubmission - Version 2 | ||
Submitted | Manuscript version 2 | |
31 Jul 2022 | Reviewed | Reviewer Report |
1 Aug 2022 | Reviewed | Reviewer Report - Liangyuan Chen |
13 Aug 2022 | Author responded | Author comments - Jin-Tao He |
Resubmission - Version 3 | ||
13 Aug 2022 | Submitted | Manuscript version 3 |
15 Aug 2022 | Author responded | Author comments - Jin-Tao He |
Resubmission - Version 4 | ||
15 Aug 2022 | Submitted | Manuscript version 4 |
18 Aug 2022 | Author responded | Author comments - Jin-Tao He |
Resubmission - Version 5 | ||
18 Aug 2022 | Submitted | Manuscript version 5 |
9 Sep 2022 | Reviewed | Reviewer Report |
Resubmission - Version 6 | ||
Submitted | Manuscript version 6 | |
Publishing | ||
19 Sep 2022 | Editorially accepted | |
27 Oct 2022 | Article published | 10.1186/s12890-022-02173-x |